Hansoh Pharmaceutical Group Co (HKSE:03692) Total Stockholders Equity : HK$28,214 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Total Stockholders Equity?

Hansoh Pharmaceutical Group Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$28,214 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hansoh Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$4.76. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hansoh Pharmaceutical Group Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.17.

Hansoh Pharmaceutical Group Co Total Stockholders Equity Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Total Stockholders Equity Chart

Hansoh Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

14,515.08

21,190.32

24,524.67

25,290.18

28,213.78

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial									24,524.67	24,763.95	25,290.18	26,442.83	28,213.78

Hansoh Pharmaceutical Group Co (HKSE:03692) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hansoh Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(28213.778	-	0)	/	5927.82
	=	4.76

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hansoh Pharmaceutical Group Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4593.089	+	114.245)	/	28213.778
	=	0.17

Hansoh Pharmaceutical Group Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

3KY:Germany

Address

287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210

Website

https://www.hspharm.com

Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines